Deans' stroke musings: The Fast-Acting Drug That Lifts Severe Depression In 40 Minutes

Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Friday, December 22, 2017

The Fast-Acting Drug That Lifts Severe Depression In 40 Minutes

Since your doctor has no stroke protocols to get you 100% recovered you might need this. Be careful out there.
http://www.spring.org.uk/2017/12/drug-anti-suicide.php?omhide=true

The drug takes effect within hours.

Ketamine — a type of anaesthetic — has anti-suicidal effects within hours of administration, new research finds.
The drug performed better than a commonly used sedative called midazolam.
The drug could be useful for those experiencing suicidal thoughts.
Dr Michael Grunebaum, the study’s first author, said:

“There is a critical window in which depressed patients who are suicidal need rapid relief to prevent self-harm.
Currently available antidepressants can be effective in reducing suicidal thoughts in patients with depression, but they can take weeks to have an effect.
Suicidal, depressed patients need treatments that are rapidly effective in reducing suicidal thoughts when they are at highest risk.
Currently, there is no such treatment for rapid relief of suicidal thoughts in depressed patients.”

The study compared ketamine with midazolam in a group of 80 people experiencing suicidal thoughts.
Those given ketamine showed a greater reduction in suicidal thoughts.
Researchers found that the beneficial effects of ketamine persisted six weeks later.
Dr Grunebaum said:

“This study shows that ketamine offers promise as a rapidly acting treatment for reducing suicidal thoughts in patients with depression.
Additional research to evaluate ketamine’s antidepressant and anti-suicidal effects may pave the way for the development of new antidepressant medications that are faster acting and have the potential to help individuals who do not respond to currently available treatments.”